IL112011A - Crystalline hydrates of acid 5 azamido 2,3,4,5, tetrahydroxy 4 guanidimine D Gilzero D galacto non anapyranosonic preparation and pharmaceutical preparations containing or - Google Patents

Crystalline hydrates of acid 5 azamido 2,3,4,5, tetrahydroxy 4 guanidimine D Gilzero D galacto non anapyranosonic preparation and pharmaceutical preparations containing or

Info

Publication number
IL112011A
IL112011A IL11201194A IL11201194A IL112011A IL 112011 A IL112011 A IL 112011A IL 11201194 A IL11201194 A IL 11201194A IL 11201194 A IL11201194 A IL 11201194A IL 112011 A IL112011 A IL 112011A
Authority
IL
Israel
Prior art keywords
crystalline form
guanidino
glycero
tetradeoxy
hydrate
Prior art date
Application number
IL11201194A
Other languages
English (en)
Hebrew (he)
Other versions
IL112011A0 (en
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of IL112011A0 publication Critical patent/IL112011A0/xx
Publication of IL112011A publication Critical patent/IL112011A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11201194A 1993-12-17 1994-12-16 Crystalline hydrates of acid 5 azamido 2,3,4,5, tetrahydroxy 4 guanidimine D Gilzero D galacto non anapyranosonic preparation and pharmaceutical preparations containing or IL112011A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325841A GB9325841D0 (en) 1993-12-17 1993-12-17 Chemical compounds

Publications (2)

Publication Number Publication Date
IL112011A0 IL112011A0 (en) 1995-03-15
IL112011A true IL112011A (en) 1998-08-16

Family

ID=10746778

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11201194A IL112011A (en) 1993-12-17 1994-12-16 Crystalline hydrates of acid 5 azamido 2,3,4,5, tetrahydroxy 4 guanidimine D Gilzero D galacto non anapyranosonic preparation and pharmaceutical preparations containing or

Country Status (44)

Country Link
US (2) US6294572B1 (fr)
EP (1) EP0734382B1 (fr)
JP (1) JP3317972B2 (fr)
KR (1) KR100403256B1 (fr)
CN (2) CN1502621A (fr)
AP (2) AP9600810A0 (fr)
AT (1) ATE199255T1 (fr)
BG (1) BG63338B1 (fr)
BR (2) BR9408340A (fr)
CA (1) CA2177990C (fr)
CO (1) CO4340619A1 (fr)
CZ (1) CZ289234B6 (fr)
DE (1) DE69426726T2 (fr)
DK (1) DK0734382T3 (fr)
EE (1) EE03353B1 (fr)
EG (1) EG20597A (fr)
ES (1) ES2155517T3 (fr)
FI (1) FI120453B (fr)
GB (1) GB9325841D0 (fr)
GR (1) GR3035681T3 (fr)
HK (1) HK1014187A1 (fr)
HR (1) HRP941001B1 (fr)
HU (1) HU221971B1 (fr)
IL (1) IL112011A (fr)
IS (1) IS4240A (fr)
MA (1) MA23396A1 (fr)
MY (1) MY116221A (fr)
NO (1) NO314759B1 (fr)
NZ (1) NZ277789A (fr)
OA (2) OA10325A (fr)
PE (1) PE31095A1 (fr)
PL (1) PL186384B1 (fr)
PT (1) PT734382E (fr)
RO (1) RO114792B1 (fr)
RU (1) RU2134690C1 (fr)
SA (1) SA94150417B1 (fr)
SG (1) SG46669A1 (fr)
SI (1) SI0734382T1 (fr)
SK (1) SK282972B6 (fr)
SV (1) SV1994000076A (fr)
TW (1) TW452577B (fr)
UA (1) UA46723C2 (fr)
WO (1) WO1995016680A1 (fr)
ZA (1) ZA9410003B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
JP3300365B2 (ja) 1995-02-27 2002-07-08 ギリアード サイエンシーズ，インコーポレイテッド ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
ATE211468T1 (de) * 1996-07-22 2002-01-15 Sankyo Co Neuraminsäuredervate, ihre herstellung und medizinische verwendung
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI291462B (en) * 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
ES2640001T3 (es) * 2011-12-16 2017-10-31 Daiichi Sankyo Company, Limited Procedimiento de producción de un derivado del ácido neuramínico
CN109232677B (zh) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
CA2081068C (fr) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Derives antiviraux de 2-desoxy-2,3-deshydro a substituant en 4 de l'acide .alpha.-d-neuraminique
US5639786A (en) 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2177990C (fr) 2000-04-25
US6294572B1 (en) 2001-09-25
DE69426726T2 (de) 2001-06-21
AU1314495A (en) 1995-07-03
SV1994000076A (es) 1995-10-26
SG46669A1 (en) 1998-02-20
CN1132829C (zh) 2003-12-31
HK1014187A1 (en) 1999-09-24
HU9601642D0 (en) 1996-08-28
FI962464A (fi) 1996-06-13
FI962464A0 (fi) 1996-06-13
GR3035681T3 (en) 2001-06-29
HRP941001A2 (en) 1997-06-30
TW452577B (en) 2001-09-01
US20020037865A1 (en) 2002-03-28
BG63338B1 (bg) 2001-10-31
NO314759B1 (no) 2003-05-19
PL315055A1 (en) 1996-09-30
HRP941001B1 (en) 2001-06-30
GB9325841D0 (en) 1994-02-23
EP0734382B1 (fr) 2001-02-21
MY116221A (en) 2003-12-31
DE69426726D1 (de) 2001-03-29
SI0734382T1 (en) 2001-08-31
MA23396A1 (fr) 1995-07-01
BR1100548KB1 (pt) 2011-11-01
RU2134690C1 (ru) 1999-08-20
CN1502621A (zh) 2004-06-09
OA11275A (en) 2002-11-20
ATE199255T1 (de) 2001-03-15
CZ289234B6 (cs) 2001-12-12
SK282972B6 (sk) 2003-01-09
OA10325A (en) 1997-10-07
FI120453B (fi) 2009-10-30
BG100709A (bg) 1997-01-31
HU221971B1 (hu) 2003-03-28
NZ277789A (en) 1999-04-29
ZA9410003B (en) 1995-07-25
NO962545L (no) 1996-06-14
EE03353B1 (et) 2001-02-15
RO114792B1 (ro) 1999-07-30
HUT74938A (en) 1997-03-28
EG20597A (en) 1999-09-30
IS4240A (is) 1995-06-18
AP9600810A0 (en) 1996-07-31
KR100403256B1 (ko) 2004-04-30
SA94150417B1 (ar) 2005-12-18
AP9400705A0 (en) 1995-01-31
PE31095A1 (es) 1995-10-18
UA46723C2 (uk) 2002-06-17
AP541A (en) 1996-10-01
JP3317972B2 (ja) 2002-08-26
PL186384B1 (pl) 2004-01-30
BR9408340A (pt) 1997-08-19
CO4340619A1 (es) 1996-07-30
CA2177990A1 (fr) 1995-06-22
CZ169396A3 (en) 1996-11-13
CN1142820A (zh) 1997-02-12
JPH09506601A (ja) 1997-06-30
EP0734382A1 (fr) 1996-10-02
NO962545D0 (no) 1996-06-14
PT734382E (pt) 2001-06-29
ES2155517T3 (es) 2001-05-16
WO1995016680A1 (fr) 1995-06-22
SK78596A3 (en) 1997-03-05
AU689185B2 (en) 1998-03-26
IL112011A0 (en) 1995-03-15
DK0734382T3 (da) 2001-03-19

Similar Documents

Publication Publication Date Title
EP0734382B1 (fr) Derives cristallins d'acide n-acetyle neuraminique et leurs procedes de preparation
EP1973894B1 (fr) Procede preparation de docetaxel amorphe, cristallin anhydre ou cristallin hydrate
US4873330A (en) A process for the preparation of anhydrous, stable, crystalline delta-form of prazosin hydrochloride
IL293252A (en) Crystalline form of a 7h-benzo[7]annulene-2-carboxylic acid derivative
HU181839B (en) Process for producing diacyl-citosin-arabinosid derivatives
US4978752A (en) Crystals of cephem hydrochloride
AU689185C (en) Crystalline N-acetyl neuraminic acid derivatives and processes for their preparation
HU218423B (hu) N-acetil-neuraminsav-származékok és eljárás előállításukra
AU5108893A (en) Synthesis of n-acetyl neuraminic acid derivatives
WO2018067805A1 (fr) Formes à l'état solide de sotagliflozine
WO2003055885A1 (fr) Nouveau derive de triazolobenzazepine tricyclique cristalline
US6150541A (en) 4,10-β-diacetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-9-oxo-19-norcyclopropa[g]t ax-11-en-13α-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate dihydrate and its process of preparation
AU713086B2 (en) 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation
HU179752B (hu) Eljárás S-metil-metionin-szulfóniumkloríd előállítására
DE2722164A1 (de) Bicyclische verbindungen
CH666481A5 (de) Verfahren zur herstellung von 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamid.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
ERR Corrigendum

Free format text: ADD NUMBER OF PATENT OF ADDITION 147990

KB Patent renewed
EXP Patent expired